FORM VI
[See Paragraph 2 and 20(2)]

YEARLY INFORMATION ON TURNOVER ANDALLOCATION OF SALES AND EXPENSES :-

  1. Name of the manufacturer.
  2. Address of the Registered/Head Office / Factory.
  3. Accounting year.
  4. Turnover of Bulk Drugs;-
Sl.No

  

Name of the Bulk Drug

 

 Unit Production Quantity

Captive Consumption

Domestic Sale

Exports
Quantity Value Excl.ED (Rs. Lakhs) Quantity Sale Value Excl.ED (Rs.Lakhs) Quantity FOB Value (Rs. Lakhs)
1 2 3 4 5 6 7 8 9 10

SCHEDULED BULK DRUGS
1.
2.
3 etc
NON-SCHEDULED BULK DRUGS
1.
2.
3.etc
TOTAL

I. SCHEDULED FORMULATIONS
1. Own Produced
2. Purchased
   (a) Indigenous
   (b) Imported
II. NON-SCHEDULED BULK DRUGS
1. Own Produced
2. Purchased
(a) Indigenous
(b) Imported
------------------------------------------------------------------------------
TOTAL
------------------------------------------------------------------------------
6.Allocation of sales and expenses as shown in the Audited Profit & Loss Account (In Rupees)

S.No.

 

 Particulars Total as per
P&L
account		 Allocation to bulk drugs own produced

Allocation to Formulations

 Other activities

 

Basis of Allocation

Purchased

 Export
Sales  		Total
Indigenous Imported
1 2 3 4 5 6 7 8 9 10

A. INCOME

  1. Sales Income (Excl. Excise duty and other taxes)
  2. Cash Subsidy (if any)
  3. Other Income (Incl. Import incentives)

-----------------------------------------------------------------------------------
TOTAL (1+2+3)
------------------------------------------------------------------------------------
B. EXPENSES

  1. Raw Materials
  2. Packing Materials
  3. Power & Fuel
  4. Salaries and Wages
  5. Stores and Spares
  6. Repair and Maintenance
  7. Insurance
  8. Depreciation
  9. Royalty
  10. Interest
  11. Head Office-Expenses
  12. Dealer's Commission and Discount
  13. Research and Development Expenses
  14. Other Expenses

------------------------------------------------------------------------------
TOTAL (4 TO 17)
------------------------------------------------------------------------------
C. PROFIT BEFORE TAX (A-B)
D. PROFIT BEFORE TAX (As a %age of Sales income)
[C x 100/A]

NOTES:

  1. The basis of allocation should be reasonable and followed consistently.
  2. The figures against S. No . A under Cols. 4 to 9 of item 6 should tally with the figures under items 4 and 5 respectively of this form
  3. This form should be certified by the Company's Auditors.

The information furnished above is correct and true to the best of my knowledge and belief.

                      Authorised Signatory:

Place:           Name:
Date:            Designation:

[Back]